Methods : We retrospectively assessed all patients who had received a diagnosis of a rare genetic disorder after KTx.
Results : In our Center, more than 30% (278/911) of KTx recipients were diagnosed with a causal nephropathy: prevalence of rare genetic disorders in this group was 4.32% (12/278), including 2,8 dihydroxyadeninuria (2,8 DHA)-disease (n=2), HNF-1B associated nephropathy (n=2), UMOD-related nephropathy (n=5), Fabry disease (n=1), INF2 focal segmental glomerulosclerosis (n=1) and Senior-Loken syndrome (n=1). 2,8 DHA-nephropathy relapsed in both patients causing an acute renal failure and jeopardising the graft.
Conclusions : KTx recipients without a diagnosis of causal nephropathy appear to be a selected population in which rare genetic diseases might be more common than expected. As even a belated diagnosis after KTx can have a significant impact on graft and patient survival and on other family members, this possibility should be evaluated in KTx recipients without a known causal nephropathy (read more) Print this post
No comments:
Post a Comment